Literature DB >> 36066670

Robot-assisted transthoracic hybrid esophagectomy versus open and laparoscopic hybrid esophagectomy: propensity score matched analysis of short-term outcome.

Therese Reinstaller1, Daniela Adolf2, Eric Lorenz1, Roland S Croner1, Frank Benedix3.   

Abstract

PURPOSE: Minimally invasive en-bloc esophagectomy is associated with a reduction of postoperative morbidity. This was demonstrated for both total minimally invasive and hybrid esophagectomy. However, little is known about any benefits of robotic assistance compared to the conventional minimally invasive technique, especially in hybrid procedures.
METHODS: For this retrospective study, all consecutive patients who had undergone elective esophagectomy with circular stapled intrathoracic anastomosis using the open and the minimally invasive hybrid technique at the University Hospital Magdeburg, from January 2010 to March 2021 were considered for analysis.
RESULTS: In total, 137 patients (60.4%) had undergone open esophagectomy. In 45 patients (19.8%), the laparoscopic hybrid technique and in 45 patients (19.8%), the robot-assisted hybrid technique were applied. In propensity score matching analysis comparing the open with the robotic hybrid technique, significant differences were found in favor of the robotic technique (postoperative morbidity, p < 0.01; hospital length of stay, p < 0.01; number of lymph nodes retrieved, p = 0.048). In propensity score matching analysis comparing the laparoscopic with the robotic hybrid technique, a significant reduction of the rate of postoperative delayed gastric emptying (p = 0.02) was found for patients who had undergone robotic esophagectomy. However, the operation time was significantly longer (p < 0.01).
CONCLUSIONS: En-bloc esophagectomy using the robotic hybrid technique is associated with a significant reduction of postoperative morbidity and of the hospital length of stay when compared to the open approach. However, when compared to the laparoscopic hybrid technique, only few advantages could be demonstrated.
© 2022. The Author(s).

Entities:  

Keywords:  Esophageal cancer; Minimally invasive hybrid esophagectomy; Postoperative outcome; Robot-assisted hybrid esophagectomy

Year:  2022        PMID: 36066670     DOI: 10.1007/s00423-022-02667-6

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   2.895


  13 in total

1.  The Role of Gastroesophageal Reflux and Other Factors during Progression to Esophageal Adenocarcinoma.

Authors:  William D Hazelton; Kit Curtius; John M Inadomi; Thomas L Vaughan; Rafael Meza; Joel H Rubenstein; Chin Hur; E Georg Luebeck
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-04-30       Impact factor: 4.254

2.  Robot-assisted minimally invasive thoracolaparoscopic esophagectomy versus open esophagectomy: long-term follow-up of a randomized clinical trial.

Authors:  Eline M de Groot; Sylvia van der Horst; B Feike Kingma; Lucas Goense; Pieter C van der Sluis; Jelle P Ruurda; Richard van Hillegersberg
Journal:  Dis Esophagus       Date:  2020-11-26       Impact factor: 3.429

3.  Robot-assisted minimally invasive esophagectomy (RAMIE) compared to conventional minimally invasive esophagectomy (MIE) for esophageal cancer: a propensity-matched analysis.

Authors:  E Tagkalos; L Goense; M Hoppe-Lotichius; J P Ruurda; B Babic; E Hadzijusufovic; W Kneist; P C van der Sluis; H Lang; R van Hillegersberg; P P Grimminger
Journal:  Dis Esophagus       Date:  2020-04-15       Impact factor: 3.429

4.  A meta-analysis of body mass index and esophageal and gastric cardia adenocarcinoma.

Authors:  F Turati; I Tramacere; C La Vecchia; E Negri
Journal:  Ann Oncol       Date:  2012-08-16       Impact factor: 32.976

5.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.

Authors:  Hyuna Sung; Jacques Ferlay; Rebecca L Siegel; Mathieu Laversanne; Isabelle Soerjomataram; Ahmedin Jemal; Freddie Bray
Journal:  CA Cancer J Clin       Date:  2021-02-04       Impact factor: 508.702

6.  Meta-analysis of randomized controlled trials and individual patient data comparing minimally invasive with open oesophagectomy for cancer.

Authors:  B P Müller-Stich; P Probst; H Nienhüser; S Fazeli; J Senft; E Kalkum; P Heger; R Warschkow; F Nickel; A T Billeter; P P Grimminger; C Gutschow; T S Dabakuyo-Yonli; G Piessen; M Paireder; S F Schoppmann; D L van der Peet; M A Cuesta; P van der Sluis; R van Hillegersberg; A H Hölscher; M K Diener; T Schmidt
Journal:  Br J Surg       Date:  2021-09-27       Impact factor: 6.939

Review 7.  Epidemiology of esophageal cancer: update in global trends, etiology and risk factors.

Authors:  Dustin J Uhlenhopp; Eric Omar Then; Tagore Sunkara; Vinaya Gaduputi
Journal:  Clin J Gastroenterol       Date:  2020-09-23

8.  Robot-assisted Minimally Invasive Thoracolaparoscopic Esophagectomy Versus Open Transthoracic Esophagectomy for Resectable Esophageal Cancer: A Randomized Controlled Trial.

Authors:  Pieter C van der Sluis; Sylvia van der Horst; Anne M May; Carlo Schippers; Lodewijk A A Brosens; Hans C A Joore; Christiaan C Kroese; Nadia Haj Mohammad; Stella Mook; Frank P Vleggaar; Inne H M Borel Rinkes; Jelle P Ruurda; Richard van Hillegersberg
Journal:  Ann Surg       Date:  2019-04       Impact factor: 12.969

9.  Evaluation of International Contemporary Operative Outcomes and Management Trends Associated With Esophagectomy: A 4-Year Study of >6000 Patients Using ECCG Definitions and the Online Esodata Database.

Authors:  Madhan K Kuppusamy; Donald E Low
Journal:  Ann Surg       Date:  2022-03-01       Impact factor: 12.969

10.  Open versus laparoscopically-assisted oesophagectomy for cancer: a multicentre randomised controlled phase III trial - the MIRO trial.

Authors:  Nicolas Briez; Guillaume Piessen; Franck Bonnetain; Cécile Brigand; Nicolas Carrere; Denis Collet; Christophe Doddoli; Renaud Flamein; Jean-Yves Mabrut; Bernard Meunier; Simon Msika; Thierry Perniceni; Frédérique Peschaud; Michel Prudhomme; Jean-Pierre Triboulet; Christophe Mariette
Journal:  BMC Cancer       Date:  2011-07-23       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.